pgt

PGT-M is a genetic testing technique designed to identify if there is a single-gene disorder(s) in embryos created through in vitro fertilization (IVF). These disorders, which include conditions such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, are usually caused by mutations in a single gene. By testing embryos for these genetic abnormalities before implantation, couples can select and transfer only those embryos that are free from the targeted disorder (genetic variant), avoiding the risk of passing it on to their children.

Your report will include a summary of results for each embryo biopsy sample submitted for testing. The first number in the report represents the total chromosome count, followed by sex chromosomes, followed by abnormality or normal chromosome count.

Deoxyribonucleic acid (or DNA) is the chemical novel of you.  A little less than half of your story comes from a paternal inheritance (for some people this […]

Throughout your pre-implantation testing journey, you might hear terms like PGT-A, PGT-M, PGT-SR, PGT-HLA, NGS, PCR, etc. All these letters can get pretty confusing if you aren’t sure what they mean, so let’s break it down. 

Screening is now pan-ethnic, and uses DNA platforms. Couples of mixed ethnicities are screened without regard to specific ethnicity. Over 400 disorders can be screened, identifying approximately 2% at-risk couples.